Author Affiliations: Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas (Drs McGuire and McCullough); and Department of Genetics, University of North Carolina School of Medicine, Chapel Hill (Dr Evans).
Whole-genome sequencing and whole-exome sequencing (WGS/WES) have become increasingly affordable and accessible to individuals. There are currently 3 main pathways through which a person can receive WGS/WES: as a research participant in a genomic study; through a direct-to-consumer personal genome company; or as part of clinical care. In the research context, the extent to which findings from WGS/WES are communicated to study participants and used to inform their clinical care is a topic of much debate, but guidelines suggest that investigators may have an obligation to offer at least some results to study participants.1
McGuire AL, McCullough LB, Evans JP. The Indispensable Role of Professional Judgment in Genomic Medicine. JAMA. 2013;309(14):1465–1466. doi:10.1001/jama.2013.1438
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: